Wednesday, 8 September 2021
Thousands of cancer patients could qualify for 'effective and valuable' treatment
Thousands of cancer patients could qualify for 'effective and valuable' treatment Some 8,000 people in England with hormone-sensitive or hormone-relapsed prostate cancer will be eligible for apalutamide treatment after it was recommended by a health watchdog. The Daily Mail
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment